Phase 2 data from ROSETTA Lung-02, a global randomized Phase 2/3 trial of pumitamig (PD-L1 × VEGF-A bsAb) + chemotherapy in 1L NSCLC (JADPRO 2026) - Oct 16, 2026 - Abstract #JL1425ES; Pres time: Oct 17, 2026; 11:00 AM - 12:00 PM; Location: Exhibit Hall C; No abstract available
Clinical • P2/3 data • Lung Cancer • Non Small Cell Lung Cancer • Solid Tumor • PD-L1
|
|
Solange Peters1; Youngjoo Lee2; Mustafa Erman3; Stephen V. Liu4; Benjamin Solomon5; Terufumi Kato6; Shun Lu7; Sanjay Popat8; Ulug Mutlu Gunaydin9; René Bartz10; Vikesh Patel11; Kevin Tsai9; Li Li9; Uchechukwu Dimkpa10; Claudia-Nanette Gann10; Aurora O’Brate12; Ilhan Celik10, Özlem Türeci10; Ugur Sahin10; Byoung Chul Cho13
|